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Background: Proinflammatory cytokine interleukin-1beta (IL-1β) is expressed at high levels in the developing brain
and declines to low constitutive levels in the adult. However, the pathophysiological function of IL-1β during brain
development remains elusive. In this study, we investigated the role of IL-1β in neuronal migration.
Methods: The Boyden transwell assay was used to examine the effects of IL-1β on the migration of dissociated
primary cortical neurons. To determine the role of IL-1β in neuron leading process pathfinding, we employed a
growth cone turning assay. In utero electroporation combined with RNAi technology was used to examine the
neuronal migration in vivo during brain development in Sprague–Dawley rats.
Results: IL-1β at concentrations ranging from 0.1 to 10 ng/mL in the lower chamber of a transwell induced a
significant increase in the number of migrating neurons in a dose-dependent manner. When IL-1β was simultaneously
put in both the upper and lower chambers to eliminate the gradient, no significant differences in cell migration were
observed. IL-1 receptor antagonist IL-1RA dose-dependently blocked the attractive effect of IL-1β on neuronal
migration. Microscopic gradients of IL-1β were created near the growth cones of isolated neurons by repetitive
pulsatile application of picoliters of a IL-1β-containing solution with a micropipette. We found that growth cones
exhibited a clear bias toward the source of IL-1β at the end of a one hour period in the IL-1β gradient. No significant
difference was observed in the rate of neurite extension between IL-1β and controls. We electroporated specific
siRNA constructs against IL-1R1 mRNA into cortical progenitors at embryonic day 16 and examined the position and
distribution of transfected cells in the somatosensory cortex at postnatal day 5. We found that neurons transfected
with IL-1R1-siRNA displayed a severe retardation in radial migration, with about 83% of total cells unable to arrive at
the upper cortical layers.
Conclusions: Our study suggests an essential contribution of IL-1β to neuronal migration during brain development,
which provides a basis to understand the physiological roles of IL-1β in the developing brain and could have significant
implications for the prevention of some neurodevelopment disorders due to abnormal neuronal migration.
Keywords: IL-1beta, Neuronal migration, in utero electroporation, Brain developmentBackground
Interleukin-1beta (IL-1β), one of the most widely studied
proinflammatory cytokines, is expressed at high levels in
the brain during prenatal and postnatal development
and declines to low constitutive levels in the adult [1,2],
suggesting its important role in brain development.
Mounting evidence shows that exposure to environmental
insults as well as other adverse events during brain* Correspondence: jiangwen@fmmu.edu.cn
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unless otherwise stated.development, such as brain injury, infection and stress,
can cause some neurodevelopmental disorders, such as
cortical dysplasia [3]. IL-1β can be significantly activated
in the central nervous system (CNS) by these injuries [4].
Elevated levels of IL-1β in the circulation shortly after
preterm birth are also associated with increased risk of
neurodevelopmental disorders [5]. This evidence indicates
that dysfunction of IL-1β signaling might be involved in
the pathogenesis of some neurodevelopmental disorders.
Previous studies showed that IL-1β can regulate the
migration of many types of cell, such as smooth muscle cells
[6], tumor cells [7], airway epithelial cells [8], neutrophil [9]. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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revealed that IL-1β was able to attract the migration
of cultured cortical neurons. Neuronal migration is an
important feature of the cortical development stage,
during which postmitotic neurons migrate away from the
ventricular zone along radial glial fibers and toward the
surface of the cortical plate. Once disturbance of normal
migration occurs, neurons may accumulate in unusual
areas (heterotopias), resulting in either focal neuronal
heterotopias (nodular heterotopias) or diffuse band he-
terotopias in the white matter (pachygyrias/lissencephalies,
double cortex syndrome) [11]. Thus, studies of whether
IL-1β regulates neuronal migration are important to
further our understanding of brain development and the
pathogenesis of some neurodevelopmental disorders.
In this study, we first investigated the effect of IL-1β
on neuronal migration in vitro by using a transwell
migration assay and growth cone turning assay. Then
we applied RNAi technology combined with in utero
electroporation to demonstrate that IL-1β can guide the
radial migration during development of the rat neocortex.
Methods
Animals
All pregnant Sprague–Dawley rats used in the present
study were provided by the Fourth Military Medical
University Animal Center (Xi’an, China) and SLAC
Laboratory Animal Co. Ltd (Shanghai, China). The
rats were housed under controlled temperature and
light conditions (12-hour light/dark cycle with lights
on at 8:00 AM), with ad libitum access to food and
water. The day at which a vaginal plug was detected
was designated embryonic day 0 (E0). All experimental
procedures involving rats were in strict accordance with
the guidelines established by the US National Institutes of
Health (NIH) and were approved by the Fourth Military
Medical University Animal Care Committee. Procedures
for in utero electroporation and growth cone turning assay
were approved by the Animal Care and Administration
Committee of the Institute of Neuroscience, Shanghai
Institute for Biological Sciences, Chinese Academy of
Sciences.
Cell culture and immunocytochemistry
Primary culture of cerebral cortical neurons was per-
formed in accordance with previous methods [12].
Briefly, cortical tissues from E16 rats were dissected
and digested by 0.125% trypsin in phosphate-buffered
saline (PBS), and dissociated neurons were plated into 35
mm dishes coated with 100 mg/mL poly-D-lysine. In
transfection experiments, cells were transfected with 3 μg
of different plasmids by using the Amaxa Nucleofector kit
(Amaxa GmbH, Cologne, Germany) following the protocol
provided by the manufacturer.For the detection of IL-1R1 expression in vitro, cul-
tured cortical neurons at five day in vitro (DIV) were fixed
with 4% paraformaldehyde. Then, double immunofluores-
cence staining with anti-IL-1R1 (polyclonal antibody,
Abcam, Cambridge, UK, 1:100) and anti-Tuj1 (polyclonal
antibody, Millipore, Bilerica, MA, USA, 1:1000) was
performed according to the protocol described previously
[13]. The specificity of immunolabeling was verified by
controls in which the primary antibody was omitted.
Cell migration assay
Migration of dissociated primary cortical neurons was
assayed by using a Boyden transwell system (8 μm pore
size; Corning Costar, NY, USA) as described previously
[14]. Before seeding, both sides of the transwell were coated
overnight with poly-D-lysine (30 μg/mL, Sigma-Aldrich,
Saint Louis, MO, USA). Serum-free medium, 250 μl,
(neurobasal medium, 2% B27, Gibco, Carlsbad, CA, USA)
containing dissociated cells (2 × 105 cells per well) was
added to the upper insert of a chamber with or without
any other reagents. In the bottom chamber, 750 μl of
serum-free medium (Neurobasal medium, 2% B27, Gibico)
with or without any other reagents was added. Reagents
used were IL-1β (PeproTech, London, UK, 0.1 ng/ml,
1 ng/ml, 10 ng/ml) and IL-1RA (R & D, Minneapolis,
Minn., USA, 1 ng/ml, 10 ng/ml, 100 ng/ml). Twenty hours
after seeding, cells were fixed with 4% paraformaldehyde,
and cells attached to the upper side of the membranes were
thoroughly scraped off. Cells attached to the bottom side of
the membranes were stained with coomassie brilliant blue.
Cells were counted from five randomly chosen fields
(magnification, × 200) for each membrane under the micro-
scope. Each experiment was repeated at least four times.
Growth-cone turning assay
Cerebellar tissues from Sprague–Dawley rats (Postnal
day (P) 0 to P2) were incubated in 0.1% trypsin (Sigma)
in PBS for 10 minutes at 37°C, followed by trituration.
Dissociated cells were resuspended and plated on
coverslips coated with laminin (25 mg/ml; Sigma)
and were used for experiments 18 to 24 hours after
plating at room temperature (20 to 22°C). Quantitative
assay of growth cone turning was performed according
to a method described previously [15]. The pipette tip
(1 μm opening) containing the chemical was placed
100 μm away from the center of the growth cone of
an isolated neuron and at an angle of 45° with respect to
the initial direction of neurites (indicated by the last
10 μm segment of the neurite). A standard pressure
pulse of 3 psi was applied at a frequency of 2 Hz with
durations of 20 ms. The turning angle was defined by the
angle between the original direction of neurite extension
and a straight line connecting the positions of the growth
cone at the onset and the end of the one-hour period.
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trajectory of net neurite growth over the one-hour period.
Only those growth cones with net extension >10 μm over
the one-hour period were included for analysis of turning
angles. Data are presented as mean ± standard error of the
mean (SEM). Statistical significance was analyzed by
Kolmogorov–Smirnov test.
Plasmid construction
The IL-1R1-siRNA sequences were designed using an
online design tool (http://dharmacon.gelifesciences.com)
and cloned into a pSuper vector under the control of H1





Scramble control (Scramble): 5′-CAGTCGCGTTTGC
GACTGG-3′.
To construct the overexpression plasmid of the RNAi-
resistant human IL-1R1 homologue (h-IL-1R1), full-length
human IL-1R1 was amplified by PCR using primers
IL-1R1 hFW and IL-1R1 hRW from human muscle
cDNA (a gift from Dr. Shi) and subcloned into the
AscI/XhoIsite of pCAG-IRES-EGFP. The sequences of the
primers used are shown in Table 1. All the re-constructed
plasmids were verified by sequencing.
Western blotting
Western blotting was performed as described previously
[12,14]. Briefly, primary cultured neurons were lysed
in 0.2 mL of lysis buffer (0.1% sodium dodecyl sulfate,
1% Nonidet P-40, 50 mM N-2-hydroxyethylpiperazine-N-
2-ethanesulfonic acid (pH 7.4), 2 mM ethylenediaminetet-
raacetic acid (EDTA), 100 mM NaCl, 5 mM sodium
orthovanadate, and 40 M p-nitrophenyl phosphate)
with 1% Protease Inhibitor Mixture Set I (Calbiochem,
Hofheim, Germany). The total protein concentration of
the samples was measured by using the Bio-Rad RC/DC










IL-1R1 hRW 5'-CCGCTCGAGCTACCCGAGAGGCACGTGAG-3'Samples of the protein (50 μg) were loaded per lane on
12% SDS-polyacrylamide gels and transferred to nitro-
cellulose membranes. The samples were blocked with 5%
non-fat milk in Tris-buffered saline with Tween (TBST) for
two hours and incubated over night at room temperature
with rabbit-derived polyclonal anti-IL-1R1 antibody
(Abcam, USA, 1:1000). As a protein loading control, the
samples were also incubated with mouse-derived mono-
clonal anti-α-tubulin (Sigma, USA, 1:3000). After being
washed with PBS, the samples were incubated for one hour
with goat anti-rabbit immunoglobulin G (IgG) conjugated
to horseradish peroxidase (1:3000, Bio-Rad, USA). The
density of western blotting bands was measured with the
Image Quant 5.2 software (GE Healthcare Life Sciences)
and quantified as previously reported [12,14].
In utero electroporation
Plasmids were transfected by using in utero electroporation
(IUE) in accordance with previous methods [12]. Multi-
parous Sprague–Dawley rats on E16 were anesthetized with
10% chloral hydrate (3.5 ml/kg) intraperitoneally. For elec-
troporation of two vectors, a mixture of EYFP (6 mg/ml)
and siRNA (6 mg/ml) constructs was prepared at a ratio of
1:1. Uteruses were exposed, and then 15 to 20 μg of plasmid
mixed with Fast Green (2 mg/ml; Sigma) was injected by
trans-uterus pressure microinjection into the lateral ven-
tricle of embryos. Next, electric pulses were generated by a
pulse generator (BTX T830) and applied to the cerebral
wall at five repeats of 60 V for 50 ms, with an interval of
100 ms. In some experiments, bromodeoxyuridine (BrdU;
Sigma) was injected at 100 mg/kg intraperitoneally twice
every 30 minutes 24 hours after in utero electroporation.
Embryonic brains were directly removed and fixed with
4% paraformaldehyde, and postnatal brains at appropriate
ages were removed and fixed in 4% paraformaldehyde after
transcardial perfusion. For fluorescence immunostaining,
both fetal and postnatal brains were cryopreserved in
optimal cutting temperature (OCT) compound (Sakura
Finetek, Torrence, CA, USA). Coronal cryostat sections of
30 μm were cut on a freezing microtome and immediately
processed for immunostaining by the following three-step
free-floating protocol: blocking of nonspecific antigenic
sites in 5% bovine serum albumin plus 0.2% Triton X-100,
overnight incubation with primary antibodies, and
overnight incubation with secondary antibodies. The
primary antibodies used were anti-IL-1R1 (polyclonal
antibody, Abcam, 1:100), anti-Tuj1 (polyclonal antibody,
Millipore, 1:1000), anti-GFP (polyclonal antibody, Invitrogen,
Carlsbad, CA, USA, 1:1000), anti-BrdU (monoclonal
antibody, Sigma, 1:200) and anti-Nestin (monoclonal anti-
body, Abcam, 1:500). Fluorescently conjugated monoclo-
nal or polyclonal IgG Alexa 488 or Alexa 633 (Molecular
Probes; Eugene, OR, 1:1,000) were used as secondary anti-
bodies. Images were acquired using an F1000 confocal
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Photoshop CS. For comparison of neuron distribution, the
number of GFP+ or BrdU+ neurons in each subregion
(layers II and III, layers IV–VI, IZ-VZ-WM) was counted
to calculate the percentages of neurons in each region.
Statistical analysis
All results are expressed as mean ± SEM. Unless otherwise
indicated, one way analysis of variance (ANOVA)
followed by a Bonferroni post hoc test was used to assess
the statistical difference. Statistical significance was set at
P <0.05. Data management and statistical analyses were
performed using SPSS (v11.0).
Results
IL-1R1 is expressed in rat cortical neurons in vitro and
in vivo
First, we examined whether rat cortical neurons express
IL-1R1. Primary cultured neurons from rat cortical tissueFigure 1 IL-1R1 is expressed in rat cortical neurons in vitro and in viv
cells colocalized with IL-1R1 in cultured cortical neurons (A-C) and in the c
in D-F are shown in high magnification in G-I, respectively. P, postnatal dawere identified by immunostaining with anti-Tuj1 as
shown in Figure 1A. We found that there was a
strong IL-1R1 immunoreactivity in cortical neurons
and that the reactive products were distributed in
both the cytoplasm and nuclei of the cells (Figure 1B-C).
No immunoreactive products were observed in the
methodological control, in which the primary anti-IL-1RI
antibody was omitted. To further examine the expression
of IL-1R1 in cortical neurons in vivo, coronal sections of
rat neocortex at P0 were double stained for IL-1R1 and
Tuj1. In agreement with the in vitro results, Tuj1-positive
neurons expressed IL-1R1 (Figure 1D-I). Although the
intensity of immunostaining varied from cell to cell, almost
all neurons were intensely immunolabeled with IL-1R1.
IL-1β attracts migration of cortical neurons in vitro
Then, we investigated whether IL-1β can regulate neuronal
migration in vitro by using a transwell migration assay
(Figure 2A). Cultured cortical neurons were plated ino. Double-labeling immunofluorescence showed that Tuj1-positive
oronal sections of the rat neocortex at P0 (D-F). The selected regions
y. Scale bar, 100 μm.
Figure 2 IL-1β attracts migration of cortical neurons in vitro. (A) Schematic diagram of transwell assay. (B, C) Photomicrographs of stained
cells that crossed the 8 μm pore after 20 hours of migration in the absence (B) or presence (C) of IL-1β (1 ng/mL) in the lower chamber. Scale
bar, 100 μm. (D) Number of migrated neurons normalized to the value of the parallel control when IL-1β was added to the lower chamber at
concentrations of 0.1 ng/mL, 1 ng/mL and 10 ng/mL, respectively. (E) Number of migrated neurons normalized to the value of the parallel control
when IL-1β was added to the upper chamber, lower chamber and both, respectively. (F) Number of migrated neurons normalized to the value of
the parallel control when IL-1RA at different concentrations was added to the upper and lower chambers before addition of IL-1β in the lower
chamber. **P <0.01 versus control group.
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concentrations ranging from 0.1 to 10 ng/mL was
added to the lower chamber. We observed that IL-1β
induced a significant increase in the number of migrated
neurons in a dose-dependent manner (Figure 2B-D). To
verify whether the results obtained could reflect a change
in chemokinetic activity, IL-1β was simultaneously put in
both the upper and lower chambers to eliminate the
gradient or was put in the upper chamber only. Under
these conditions, no significant differences in cell
migration were observed (Figure 2E), suggesting that
IL-1β is chemotactic rather than chemokinetic for neurons.
To test whether the attractive effect of IL-1β on neuronal
migration was mediated by its functional receptor IL-1R1,
the same experiments were performed in the presence of
IL-1RA at different concentrations. We found that IL-1RA
dose-dependently blocked the attractive effect of IL-1β on
neuronal migration (Figure 2F). Thus, IL-1β is capable of
attracting neuronal migration by directly binding its
specific receptor IL-1R1.
IL-1β guides axonal growth cone turning
During neocortex development, migrating neurons
possess a short leading process ending in a growth
cone, which can sense different types of extracellular
guidance cues and thereby contributes to the control
of migration direction [16]. To determine the role of
IL-1β in leading process pathfinding, we employed a
growth cone turning assay. Cerebellar granule cells wereused as a model to perform this assay because they
constitute a large, homogeneous and easily-cultured
population of cells, which maintains migratory behavior, a
characteristic that makes them very convenient for in vitro
assays [17]. Microscopic gradients of IL-1β were created
near the growth cones of isolated neurons by repetitive
pulsatile application of picoliters of IL-1β-containing
solution with a micropipette. The tip of the micropipette
was positioned at a distance of 100 μm from the growth
cone and at a 45°angle with respect to the direction of
neurite extension. The direction and total length of neurite
extension were measured one hour after the onset of
gradient. When the pipette concentration of IL-1β
was 1 μg/ml, we consistently observed an apparent
chemotropic turning response of the growth cone toward
the pipette, as illustrated in Figure 3. The growth
cone behavior of a population of neurons is shown by
superimposing traces of individual trajectories of neurite
extension over the one-hour period for a random sample
of neurons. As depicted in Figure 3C, growth cones
exhibited a clear bias toward the source of IL-1β at
the end of a one-hour period in the IL-1β gradient.
Given that brain-derived neurotrophic factor (BDNF)
has been shown to guide neuronal migration during
early development [18], we chose it as a positive control.
We found that BDNF caused marked attractive growth
cone turning whereas PBS had no significant effect on
growth cone turning (Figure 3A and B). Statistical analysis
of the turning angle further confirmed that IL-1β as well
Figure 3 IL-1β guides axonal growth cone turning. (A-C) Microscopic images of the growth cone of a cerebellar granule cell at the beginning
and the end of a one-hour exposure to a gradient of PBS, BDNF (20 μg/ml in the pipette) or IL-1β (1 μg/ml in the pipette). Superimposed traces (right)
depict the trajectory of neurite extension during the one-hour period for all neurons examined. The origin is the center of the growth cone at the
onset of the experiment, and the original direction of growth was vertical. The arrow indicates the direction of the gradient. Scale bar, 50 μm. (D) The
distribution of turning angles. For each experimental condition, the angular positions of all growth cones at the end of a one-hour exposure to a
gradient of PBS, BDNF or IL-1β are shown in the cumulative frequency plot. The percentage value refers to the percentage of growth cones with
angular position≤ a given angular value. (E) The average turning angle during the one-hour assay for all neurons examined. (F) The neurite extension
rate during the one-hour assay for all neurons examined. **P <0.01 versus PBS group. BDNF, brain-derived neurotrophic factor.
Ma et al. Journal of Neuroinflammation 2014, 11:114 Page 6 of 11
http://www.jneuroinflammation.com/content/11/1/114as BDNF is an attractive guidance molecule for the growth
cone (Figure 3D and E). No significant difference was
observed in the rate of neurite extension among IL-1β,
BDNF and PBS groups (Figure 3F).
Recent studies have shown that when the pipette tip
was positioned at a distance of 100 μm from the center
of the growth cone, the average concentration of the
chemical at the growth cone is approximately 103-fold
lower than that in the pipette [19]. This suggests that the
effective average concentration of IL-1β at the growth
cone is about 1 ng/ml, which is similar to that found to
promote neuronal migration as above mentioned.
IL-1R1 RNAi impairs radial migration of cortical neurons
Based on the effects of IL-1β on neuronal migration
in vitro, we further determined whether it plays the same
role in the radial migration of neurons during neocortex
morphogenesis in vivo. Given that a mouse knockout
does not show an expected phenotype due to genetic
compensation and/or species differences, we employed a
method of in utero RNAi to knock down IL-1R1 protein
levels in migrating neocortical neurons in rats [20]. Two
effective siRNA sequences (IL-1R1-i1 and -i2) against
IL-1R1 mRNA and a scramble siRNA sequence were
designed and cloned into the pSuper vector. The
knockdown efficiency of these siRNAs was verified by
western blotting in cultured cortical neurons. As illustratedin Figure 4A-B, IL-1R1-i1 and IL1R1-i2 markedly reduced
the expression of IL-1R1 protein, whereas scramble siRNA
produced no significant effect. Then, the siRNA constructs
were electroporated into cortical progenitors at E16 by
using in utero electroporation, with co-transfection of a
plasmid coding for EYFP to label newborn neurons derived
from these progenitors.
We examined the position and distribution of
transfected cells in the somatosensory cortex at P5
(Figure 5A). In the cortex transfected with scramble
plasmid (control), most EYFP-labeled cells (83.60 ± 2.17%)
migrated out of the subventricular zone (SVZ) and
reached the proper layers (layers II and III) (Figure 5Ba
and C) as previously reported [16,21,22]. In contrast,
neurons transfected with IL-1R1-i1 displayed a severe
retardation in radial migration, with about 83% of
total cells unable to arrive at the upper cortical layers
(layers II and III) (Figure 5Bb and C). Most ectopic cells
(62.53 ± 4.27%) did not enter the cortical plate and
stayed below the white matter. A similar perturbation
in radial migration was observed when another effective
siRNA of IL-1R1 (IL-1R1-i2) was used for co-transfection
(Figure 5Bc and C).
Notably, IL-1R1 knockdown (IL-1R1-KD) severely
affected the morphology of migrating neurons. At P5,
control cells (transfected with EYFP alone) in the
intermediate zone showed the morphology typical of
Figure 4 Down-regulation and up-regulation of IL-1R1 by specific siRNAs and h-IL-1R1, respectively. (A) Representative western blots
showing the down-regulation and up-regulation of IL-1R1 by specific siRNAs or human IL-1R1 homologue (h-IL-1R1) in cultured cortical neurons,
respectively. (B) Histograms represent the average expression of IL-1R1, normalized to the value of the parallel control. Quantitative data are
shown as mean ± SEM from three independent experiments. **P <0.01, versus scramble group. (C) Representative western blots showing the rescue
efficiency of h-IL-1R1 in cultured HEK 293 cells. RNAi-resistant h-IL-1R1 was co-transfected with IL-1R1-i1 or with CAG-GFP, respectively. (D) Quantitative
data are shown as mean ± SEM from three independent experiments. **P <0.01 versus control group. CAG-GFP = pCAG-IRES-EGFP.
Figure 5 IL-1R1 RNAi impairs radial migration of cortical neurons. (A) Schematics of IL-1R1 RNAi procedure. (B) Representative images of
coronal sections of P5 rat somatosensory cortex transfected at E16 with different siRNAs constructs using IUE including scramble control, two
effective siRNA sequences against IL-1R1 (IL-1R1-i1 and -i2) and IL-1R1 siRNA mixed with human IL-1R1 homologue (IL-1R1-i1 + hIL-1R1, rescue).
Sections were counterstained with propidium iodide (red). (C) Histograms showing the percentages of transfected cells at different regions of
P5 rat cortex. Numbers in brackets are numbers of brains analyzed in each group. Scale bar, 100 μm. **P <0.01 versus scramble group. E, embryonic
day; IUE, in utero electroporation; P, postnatal day.
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toward the cortical plate. By contrast, many cells expressing
IL-1R1-RNAi1 at this location showed misoriented and,
even inverted, leading processes (Figure 6). This abnormal
orientation of migrating neurons in P5 brains may be
explained by a gain of repulsion from the cortical plate
after IL-1R1-KD, or a lack of directionality.
To further confirm the specificity of IL-1R1-mediated
neuronal migration, we constructed a RNAi-resistant
human IL-1R1 (h-IL1R1) expression vector and verified
its efficiency in cultured cortical neurons and human
embryonic kidney 293 (HEK 293) cells, as illustrated in
Figure 4. Then, we delivered it along with IL-1R1-i1 into
the ventricular zone cells and postmitotic migrating
neurons of embryonic neocortices at E16. We observed
that the rescue of IL-1R1 expression prevented the above-
described migration defects, with most transfected neu-
rons (84.52 ± 3.24%) migrating to the appropriate layer
(Figure 5Bd and C). This indicates that the migration
retardation is caused by specific loss-of-function of IL-1R1.
Next, we asked whether IL-1R1-KD influences other
aspects of cortical development. We examined the effectFigure 6 Misorientation of leading processes of migrating neurons by
neurons from P5 cortices electroporated at E16 with control (A) or IL-1R1 s
magnification at right (B and D, respectively). Arrows and arrow heads in B
processes, respectively. Scale bar, 300 μm in A and C, 100 μm in B and D. Eof IL-1R1-KD on progenitor cell proliferation in the
SVZ. We injected BrdU intraperitoneally into pregnant rats
24 hours after IUE and analyzed the BrdU incorporation
rate after another 24 hours. We defined a BrdU index as
the percentage of BrdU+/GFP + in total transfected cells
(GFP+). The result showed no significant difference in
BrdU index between the control group (scramble
siRNA, 21 ± 1.70%) and the IL-1R1-i1 group (19 ± 2.74%)
(Figure 7A and C), suggesting that the proliferation of
cortical progenitor cells is not affected after IL-1R1-KD,
and that the defective neuronal positioning triggered by
IL-1R1-KD does not seem to be the secondary effect of
altered proliferation of transfected progenitor cells. We also
found that IL-1R1-KD did not cause detectable morphology
changes in the radial glial scaffold, along which newborn
neurons migrated, as illustrated in Figure 7B.
Discussion
It is well established that the proinflammatory cytokine
IL-1β is a key mediator of inflammation and stress in
the CNS [23]. Here, we demonstrate a novel function of
IL-1β in brain development: (1) IL-1β is able to attractIL-1R1 down-regulation. Representative images of migrating
iRNA (C). The selected regions in the left panels are shown in high
and D show migrating neurons with normal or reversed leading
, embryonic day; P, postnatal day.
Figure 7 Down-regulation of IL-1R1 did not affect the proliferation and radial glia scaffold of neural progenitor cells. (A) Representative
images showing BrdU incorporation in control (scramble sequence) and IL-1R1-i1-transfected brains. BrdU was injected intraperitoneally into
pregnant rats 24 hours after IUE, and embryos were harvested after another 24 hours. Brain sections were stained with anti-BrdU (red) and anti-GFP
(green) antibodies. (B) Images of radial glia scaffold counterstained with anti-Nestin antibody in P0 cortices electroporated with scramble or IL-1R1-i1.
The selected regions in the left panels are shown in high magnification at right. Transfection with IL-1R1-i1 did not cause obvious changes in the
morphology of radial glial scaffold in cortices. (C) Histograms showing the percentage of BrdU+/GFP + cells in total transfected cells (GFP+) (BrdU index)
in the two groups. Numbers in brackets are numbers of brains analyzed in each group. No significant differences between scramble and IL-1R1-i1 groups
were found (P= 0.22, Student’s t test). Scale bar, 100 μm. BrdU, bromodeoxuridine; P, postnatal day.
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and (2) IL-1R1-KD impairs radial migration of cortical
neurons during brain development. These findings suggest
that IL-1β signaling contributes to cortical development
by guiding neuronal migration.
Previous studies have provided a clue that inflammatory
cytokines might play a role in cell migration. Thus, acute
brain lesions with an inflammatory element in vivo
induced a reactive migration of SVZ precursor cells
toward the lesion site [24,25]. Similarly, the inflammatory
process in the brain attracted the migration of transplanted
neural precursor cells (NPCs) into the brain and spinalcord white matter [26]. Our findings further clarify that
cortical neurons express IL-1R1 and that the inflammatory
cytokine IL-1β can guide the direction of neuronal migra-
tion. A recent in vitro study showed that IL-1β inhibited
the proliferation of neural progenitor cells derived from
the E16 rat brain through activation of the SAPK/JNK
pathway by using a [3H] thymidine incorporation assay
[27]. We used in utero electroporation to show that knock-
ing down the expression of IL-1R1 in cortical progenitor
cells did not significantly affect the proliferation of
progenitor cells during development, although other
in vivo studies revealed that there was an increased
Ma et al. Journal of Neuroinflammation 2014, 11:114 Page 10 of 11
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after various brain injuries that contained inflammatory
components [28,29]. The reason for the apparent
discrepancy of the developing brain between in vivo
and in vitro studies is currently unknown.
Genetic studies in humans and mice have identified
many molecules, deficiencies of which cause defects in
neuronal migration [30]. The X-linked dysgenesis that
manifests as lissencephaly in males and subcortical
heterotopia in females [31,32] has been shown to be
due to mutations in the doublecortin gene that is
highly expressed in fetal brain. Paradoxically, genetic
deletion of doublecortin gene in mice does not cause
neocortical malformation. Similarly, Semaphorin-3A and
Robo4 have been demonstrated to guide radial migration
of cortical neurons during development [14,33], but
Semaphorin-3A -null mice or Robo4 conditional knockout
mice do not show obvious defects in cortical layering.
These observations may be attributed to the compensatory
effects of other guidance factors that play redundant
functions during development. Recently, in utero
RNAi has been introduced as an important addition
to traditional mouse knockout studies for studying
loss-of–function effects during brain development
[34]. Using in utero electroporation to knock down the
expression of IL-1R1 in cortical progenitor cells, we
observed disrupted migration of developing cortical
neurons, although IL-1R1 null mice are of normal vigor
and display no overt phenotypes or behavioral abnor-
malities [35]. We further found that co-transfection
with h-IL1R1 effectively rescued the down-regulation
of IL-1R1 in HEK 293 cells and prevented the migration
defects of cortical neurons induced by siRNA. However,
we did not verify the overexpression of h-IL1R1 in
the triple-transfected GFP-positive cortical neurons by
immunofluorescence with anti-IL-1R1 antibodies, which
may be a weakness of this study.
Current molecular and genetic studies have greatly
expanded our knowledge of brain ontogenesis as well
as the genetic mechanism of some neurodevelopment
diseases, such as malformations of cortical development
(MCD) [36], but it remains unclear how the epigenetic
factors, such as in utero irradiation, infections, trauma and
vascular-ischemic events, cause MCD. The prominent
histopathologic features in the brain of patients with
MCD include the loss of cortical lamination and neuronal
heterotopias [37], suggesting that an aberrant migration of
cortical neurons is an essential pathogenetic element. The
present study might provide a novel mechanistic clue
between IL-1β signaling and MCD. Since IL-1β upregula-
tion is part of a patterned response that unfolds after
a wide range of insults including infection, trauma,
depression and stroke [4], it would become a noticeable
target for the prevention of MCD during pregnancy.Conclusions
We first report a novel function of IL-1β during brain
development, that is, guiding the neuronal migration,
which could have significant implications for the prevention
of some neurodevelopment disorders due to abnormal
neuronal migration.
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